CHRIST GAO: Open Payments
NPI 1144855446 · RIVERVIEW, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,097 in 40 payments from 7 companies in 2025. Trend: 2023 $102 · 2024 $799 · 2025 $1,097
Food & beverage: $1,039Education: $58
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 13 | $394 |
| Optinose US, Inc. | 8 | $251 |
| GlaxoSmithKline, LLC. | 9 | $224 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| Smith+Nephew, Inc. | 1 | $59 |
| Novartis Pharmaceuticals Corporation | 3 | $52 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $44 |
Products named: DUPIXENT, Xhance, NUCALA, TULA, Rhapsido, NEFFY, FASENRA, TEZSPIRE.
Industry payments across FL — which companies pay providers there.
